Market Closed -
Other stock markets
|
After market 16:00:01 | |||
2.116 EUR | -0.42% | 2.162 | +2.17% |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ORAMED PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | -0.42% | -2.31% | +1.20% | -49.34% | -18.21% | 94.26M | - | - | - |
- Stock Market
- Equities
- ORMP Stock
- OJU1 Stock
- Charts Oramed Pharmaceuticals Inc.
- Relative Strength Chart